Apparatus and process for growing a heart valve in three-dimensions

Patent metadata

Field	Value
Publication number	US-10016461-B2
Application number	US-201314094760-A
Country	US
Kind code	B2
Filing date	Dec 2, 2013
Priority date	Dec 3, 2012
Publication date	Jul 10, 2018
Grant date	Jul 10, 2018

Abstract

The present invention relates to a heart valve and, more particularly, to a mold and process shaping and securing cells and tissue layers as they are grown in three-dimensions into a heart valve.

First claim

What is claimed is:

1. An apparatus for growing a heart valve in vitro, comprising:
a first part, the first part having a heart valve-shaped protrusion with a plurality of cusps that are formed to mimic the shape of a heart valve leaflet;
a second part, the second part having recesses and integrally formed surrounding sidewalls, the recesses being formed to receive the heart valve-shaped protrusion, where the recesses are laterally enclosed by the integrally formed surrounding sidewalls, thereby eliminating lateral access to the recesses; and
wherein at least one of the first and second parts includes an injection hole passing therethrough.

2. The apparatus as set forth in claim 1 , wherein the injection hole is centrally disposed such that material passing through the injection hole is deposited at an intersection of the plurality of cusps.

3. The apparatus as set forth in claim 2 , further comprising a scaffold for positioning between the first and second parts, the scaffold being capable of supporting three dimensional tissue formations.

4. The apparatus as set forth in claim 3 , wherein the scaffold is selected from a group consisting of a metal mesh and a gel/liquid solution.

5. The apparatus as set forth in claim 4 , wherein the first and second parts are formed of Polyether ether ketone (PEEK).

6. The apparatus as set forth in claim 5 , wherein the recesses of the second part have a tapered shape.

7. A method for growing a heart valve in vitro, comprising acts of:
positioning a scaffold between a first part and a second part, the first part having a heart valve-shaped protrusion with a plurality of cusps that are formed to mimic the shape of a heart valve leaflet and the second part having a recess and integrally formed surrounding sidewalls, such that the recess is surrounded and laterally enclosed by the integrally formed surrounding sidewalls, thereby eliminating lateral access to the recess, the recess formed to receive the heart valve-shaped protrusion;
closing the first and second parts around the scaffold such that the scaffold is enclosed within the first and second parts;
introducing a first solution of cells, through an injection hole, onto the scaffold;
incubating the first solution of cells until a first tissue layer forms;
adjusting the first part with respect to the second part to create a space around the first tissue layer;
introducing a second solution of cells, through the injection hole: and
incubating the second solution of cells until a second tissue layer forms that surrounds the first tissue layer.

8. The method as set forth claim 7 , wherein in introducing a first solution of cells, through an injection hole, the cells are introduced to an intersection of the plurality of cusps; and wherein in introducing a second solution of cells, through the injection hole, the cells are introduced through the injection hole to an intersection of the plurality of cusps.

9. The method as set forth in claim 7 , further comprising acts of:
adjusting the first part with respect to the second part to create a space around the second tissue layer;
introducing a third solution of cells, through the injection hole to an intersection of the plurality of cusps, onto the scaffold to enclose the second tissue layer; and
incubating the third solution of cells until a third tissue layer forms that surrounds the second tissue layer.

10. The method as set forth in claim 9 , wherein the first solution of cells includes smooth muscle cells, the second solution of cells includes fibroblast/myofibroblast cells, and the third solution of cells includes endothelial cells.

11. The method as set forth in claim 10 , wherein in incubating the third solution of cells, the third tissue layer endothelializes the tissues to form a heart valve that is similar to a natural tissue.

12. The method as set forth in claim 11 , wherein the scaffold is selected from a group consisting of a metal mesh and a gel/liquid solution.

13. The method as set forth in claim 12 , wherein the first and second parts are formed of Polyether ether ketone (PEEK).

14. The method as set forth in claim 13 , further comprising an act of forming the scaffold by compressing a mesh tube between a scaffolding mold first part and a scaffolding mold second part, such that upon removal from the scaffolding mold first and second parts, the mesh tube resembles a tri-leaflet valve shape.

Assignees

• Univ California

Inventors

• Alavi Seyedhamed
• Kheradvar Arash

Classifications

• A61L27/3826

  Muscle cells, e.g. smooth muscle cells · CPC title

• A61K35/34 Primary

  Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44) · CPC title

• A61L27/3886

  comprising two or more cell types · CPC title

• C12M23/20

  Material Coatings (immunocoatings C12M25/00) · CPC title

• A61L2430/20

  for reconstruction of the heart, e.g. heart valves · CPC title